According to MBS’ press release, the BBI Group, partner to the world’s leading diagnostic and healthcare organisations, has entered into a definitive agreement to acquire the Maine Biotechnology Services, Inc. (MBS) located in Portland, Maine (USA). The acquisition of MBS will expand BBI’s portfolio during a period of expansion and growth. The company provides a range of products to the diagnostic, healthcare, research food sectors globally. MBS will add antibody development to its capability and product range. Read full story
BBI Group Acquires Maine Biotechnology Services
Related Posts
Husson creates institute for leadership and workforce development
Husson University in Bangor has launched an institute dedicated to strategic leadership and workforce development training and education. Founded by the...
Swiss optics supplier acquires Portland-based Gray Optics
The acquisition of Gray Optics in Portland by a Swiss photonics firm expands the latter’s presence in the U.S. while allowing...
ElleVet Sciences, the Leading Pet CBD+CBDA Brand in the United States, Expands into Europe
PORTLAND, Maine, Feb. 15, 2023 /PRNewswire/ — ElleVet Sciences announced today that it is expanding its global reach with its new European Headquarters...